DE60100879D1 - Helicobacter felis Impfstoff - Google Patents

Helicobacter felis Impfstoff

Info

Publication number
DE60100879D1
DE60100879D1 DE60100879T DE60100879T DE60100879D1 DE 60100879 D1 DE60100879 D1 DE 60100879D1 DE 60100879 T DE60100879 T DE 60100879T DE 60100879 T DE60100879 T DE 60100879T DE 60100879 D1 DE60100879 D1 DE 60100879D1
Authority
DE
Germany
Prior art keywords
subunit polypeptides
helicobacter felis
nucleic acid
acid sequences
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60100879T
Other languages
English (en)
Other versions
DE60100879T2 (de
Inventor
Johannes Gerardus Kusters
Giovanni Cattoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60100879D1 publication Critical patent/DE60100879D1/de
Publication of DE60100879T2 publication Critical patent/DE60100879T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
DE60100879T 2000-07-17 2001-07-11 Helicobacter felis Impfstoff Expired - Fee Related DE60100879T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202565 2000-07-17
EP00202565 2000-07-17

Publications (2)

Publication Number Publication Date
DE60100879D1 true DE60100879D1 (de) 2003-11-06
DE60100879T2 DE60100879T2 (de) 2004-05-19

Family

ID=8171823

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60100879T Expired - Fee Related DE60100879T2 (de) 2000-07-17 2001-07-11 Helicobacter felis Impfstoff

Country Status (10)

Country Link
US (1) US7514547B2 (de)
EP (1) EP1176192B1 (de)
JP (1) JP2002355054A (de)
AT (1) ATE251215T1 (de)
AU (1) AU782172B2 (de)
CA (1) CA2351110A1 (de)
DE (1) DE60100879T2 (de)
DK (1) DK1176192T3 (de)
ES (1) ES2208519T3 (de)
PT (1) PT1176192E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8029777B2 (en) 2004-08-13 2011-10-04 Marshall Barry J Helicobacter system and uses thereof
JP2008509168A (ja) * 2004-08-13 2008-03-27 マーシャル，バリー，ジェー． 細菌デリバリシステム

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
US6258359B1 (en) * 1993-05-19 2001-07-10 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
WO1996033220A1 (en) * 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
JP3007037B2 (ja) * 1995-07-19 2000-02-07 秀実 高橋 ヘリコバクター・ピロリ菌ウレアーゼ蛋白由来の人工抗原及びその人工抗原によって誘発された抗体
GB2307987A (en) * 1995-12-06 1997-06-11 Univ Manchester Epitopes of the urease of Helicobacter pylori as dignostic agents; pharmaceuticals comprising such epitopes or the antibodies thereto
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
US20030158396A1 (en) * 1997-07-29 2003-08-21 Harold Kleanthous Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US5985631A (en) * 1997-09-12 1999-11-16 Oravax-Merieux Co. Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
EP1278768B1 (de) * 2000-04-27 2006-11-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Methode zur identifizierung von helicobacter antigenen

Also Published As

Publication number Publication date
JP2002355054A (ja) 2002-12-10
ATE251215T1 (de) 2003-10-15
DK1176192T3 (da) 2004-02-02
EP1176192A2 (de) 2002-01-30
DE60100879T2 (de) 2004-05-19
US7514547B2 (en) 2009-04-07
CA2351110A1 (en) 2002-01-17
ES2208519T3 (es) 2004-06-16
US20040005325A1 (en) 2004-01-08
AU5432101A (en) 2002-01-24
EP1176192A3 (de) 2002-02-06
PT1176192E (pt) 2004-01-30
AU782172B2 (en) 2005-07-07
EP1176192B1 (de) 2003-10-01

Similar Documents

Publication Publication Date Title
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
DK1219711T3 (da) Lawsonia Intracellularis vaccine
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
WO2003095480A3 (en) Brachyspira hyodysenteriae vaccine
DE60100879D1 (de) Helicobacter felis Impfstoff
ZA200602107B (en) Piroplasmid vaccine
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
TW200801034A (en) Novel sea lice vaccine
DK0995799T3 (da) Coccidiose-vacciner
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
WO2002051237A3 (en) Helicobacter proteins, nucleic acids and uses thereof
HUP0200832A2 (hu) Babesia canis oltóanyag
WO2004024769A3 (en) Ostertagia vaccine
ATE374622T1 (de) Genetische impstoffe mit adjuvans
ATE450546T1 (de) Impfstoffe mit ornithobakterium rhinotracheale- untereinheit
DE60025522D1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
TH62170A (th) วัคซีนเชื้อก่อโรค Lawsonia intracellularis
ATE460945T1 (de) Genetische adjuvanz-impfstoffe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL

8339 Ceased/non-payment of the annual fee